PPARGC1A and type 2 diabetes mellitus: Of note, we also validated the trend showing decreased PAK1 and PGC1α in T2D human skeletal muscle samples and demonstrated reduced mitochondrial activity in PAK1-deficient LHCN-M2 human myotubes, providing applicability of our findings to humans.